| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/15/1996 | CN1122576A Therapeutic strategies for immunoinfective cluster virus infections |
| 05/15/1996 | CN1122247A Vaccine composition for eliciting an immune response against N-glycolylated gangliosides and its use for cancer treatment |
| 05/15/1996 | CA2162799A1 G protein coupled receptor protein, production and use thereof |
| 05/14/1996 | US5516938 Sulfonylurea linking component |
| 05/14/1996 | US5516895 Antibodies specific towards gp 48 |
| 05/14/1996 | US5516672 Stabilized peroxidase compositions and antibody compositions |
| 05/14/1996 | US5516658 DNA encoding cytokines that bind the cell surface receptor hek |
| 05/14/1996 | US5516651 Nucleic acids encoding calcitonin receptor and uses thereof |
| 05/14/1996 | US5516643 Diagnosis |
| 05/14/1996 | US5516639 Antibodies specific for human prostate glandular kallkrein |
| 05/14/1996 | US5516637 Genetic engineering; expression |
| 05/14/1996 | US5516515 Separation of alpha interferon receptor proteins and antibodies therefor |
| 05/14/1996 | US5516512 N- and C-terminal truncation and deletion mutants of human interleukin-3 |
| 05/14/1996 | CA1338324C Monoclonal antibody for the selective immunological determination of intact procollagen peptide (type iii) and procollagen (type iii) in body fluids |
| 05/14/1996 | CA1338323C Retrovirus capable of causing aids, means and methods for detecting it in vitro |
| 05/10/1996 | CA2161265A1 Test for determining frost hardiness of conifer seedlings and protein and antibody related thereto |
| 05/09/1996 | WO1996013616A1 Peptides for detection of hepatitis c antibodies |
| 05/09/1996 | WO1996013605A1 A polyaromatic hydrocarbon (pah) immunoassay method, its components and a kit for use in performing the same |
| 05/09/1996 | WO1996013603A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4 |
| 05/09/1996 | WO1996013594A1 Tumor-specific antibody fragments, fusion proteins, and uses thereof |
| 05/09/1996 | WO1996013593A2 Soluble single chain t cell receptors |
| 05/09/1996 | WO1996013592A2 Protein kinase npk-110 |
| 05/09/1996 | WO1996013590A2 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents |
| 05/09/1996 | WO1996013585A1 A novel family of protease inhibitors, and other biologic active substances |
| 05/09/1996 | WO1996013583A2 Targeted hetero-association of recombinant proteins to multi-functional complexes |
| 05/09/1996 | WO1996013523A1 Cathepsin o2 protease |
| 05/09/1996 | WO1996013522A1 Complementarily bonded two- and three-dimensional supramolecular structures |
| 05/09/1996 | WO1996013521A1 An immunoassay for detecting immunologically non-remarkable compounds, its components and an immunoassay kit |
| 05/09/1996 | WO1996013518A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 05/09/1996 | WO1996013515A1 Novel opacity associated proteins, dna encoding the same, and methods of use thereof |
| 05/09/1996 | WO1996013277A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 05/09/1996 | WO1996013271A1 Compositions and methods for human gastrointestinal health |
| 05/09/1996 | DE4439452A1 Antikörperklassenspezifisches Entstörungsreagenz Antibody class-specific interference elimination |
| 05/09/1996 | CA2204037A1 Novel opacity associated proteins, dna encoding the same, and methods of use thereof |
| 05/09/1996 | CA2203910A1 Novel protein kinase (npk-110) |
| 05/09/1996 | CA2203875A1 Complementarily bonded two- and three-dimensional supramolecular structures |
| 05/09/1996 | CA2203827A1 Novel family of protease inhibitors, and other biologic active substances |
| 05/09/1996 | CA2203762A1 Compositions and methods for human gastrointestinal health |
| 05/09/1996 | CA2203236A1 Tumor-specific antibody fragments, fusion proteins, and uses thereof |
| 05/09/1996 | CA2201703A1 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents |
| 05/08/1996 | EP0710723A1 Cloning and expression of a gene encoding bryodin 1 from bryonia dioica |
| 05/08/1996 | EP0710720A1 Method for the production of monoclonal antibodies utilizing a germfree animal |
| 05/08/1996 | EP0710719A1 Generation of xenogeneic antibodies |
| 05/08/1996 | EP0710660A1 Imidazolinone haptens and antigens and enzyme conjugates prepared therefrom |
| 05/08/1996 | EP0710362A1 Methods for determining the invasiveness of a bladder tumor |
| 05/08/1996 | EP0710295A1 Htlv-ii nra? compositions and assays for detecting htlv infection |
| 05/08/1996 | EP0710294A1 Linear and branched peptides effective in diagnosing and detecting non-a, non-b hepatitis |
| 05/08/1996 | EP0710280A1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 05/08/1996 | EP0710278A1 Cell matrix stimulated cell attachment and hemidesmosome assembly |
| 05/08/1996 | EP0710253A1 Antibodies specific for human prostate glandular kallikrein |
| 05/08/1996 | EP0710252A1 Monoclonal antibodies to egg yolk immunoglobulins (igy) |
| 05/08/1996 | EP0710251A1 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 05/08/1996 | EP0710244A1 Immunoreactive reagents employing monoamine oxidase |
| 05/08/1996 | EP0710123A1 Adenovirus vectors for gene therapy sponsorship |
| 05/08/1996 | EP0710121A1 Method for treating multiple sclerosis |
| 05/08/1996 | EP0710116A1 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
| 05/08/1996 | EP0710110A1 Rapamycin conjugates and antibodies |
| 05/08/1996 | EP0423198B1 Antibodies specific towards hiv 1 gp 48 |
| 05/08/1996 | EP0410004B1 Immunoassay of human osteocalcin, reagent and kit therefor |
| 05/08/1996 | EP0328578B1 Antigen recognized by mca 16-88 |
| 05/08/1996 | CN1031759C Process for preparing monoclonal antibody specific to common determinant site of neutrophils and eosinophils |
| 05/07/1996 | US5514794 Antibody-drug conjugates |
| 05/07/1996 | US5514787 DNA sequences encoding human membrane cofactor protein (MCP) |
| 05/07/1996 | US5514776 Antiallergen |
| 05/07/1996 | US5514676 Amino-benzoic acids and derivatives, and methods of use |
| 05/07/1996 | US5514599 Antibodies against highly conserved amino acid sequences of insulin a process for the preparation of these antibodies and the use thereof in immunoassays |
| 05/07/1996 | US5514598 Prenatal detection of meconium |
| 05/07/1996 | US5514578 Genetic engineering |
| 05/07/1996 | US5514559 Immunologically active conjugates and method for their preparation |
| 05/07/1996 | US5514554 Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy |
| 05/07/1996 | US5514553 Immunology |
| 05/07/1996 | US5514544 Dna sequences for genetic engineering |
| 05/07/1996 | US5514542 Methods for propagating retrovirus for use in antibody assays |
| 05/07/1996 | US5514541 T-lymphotropic retrovirus monoclonal antibodies |
| 05/07/1996 | CA1338320C Resorufin derivatives |
| 05/07/1996 | CA1338318C Composition for vaccines |
| 05/02/1996 | WO1996012964A1 Receptor for a bacillus thuringiensis toxin |
| 05/02/1996 | WO1996012810A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof |
| 05/02/1996 | WO1996012809A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 05/02/1996 | WO1996012807A2 Hepatitis e virus antigens and uses therefor |
| 05/02/1996 | WO1996012805A1 Alk-7 (activin like kinase), a serine threonine kinase receptor |
| 05/02/1996 | WO1996012802A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
| 05/02/1996 | WO1996012801A1 Oral immunization with transgenic plants |
| 05/02/1996 | WO1996012791A1 Human abh |
| 05/02/1996 | WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 05/02/1996 | WO1996012741A1 Binding agents to cd23 |
| 05/02/1996 | WO1996012740A1 SYNTHETIC IgE MEMBRANE ANCHOR PEPTIDE IMMUNOGENS FOR THE TREATMENT OF ALLERGY |
| 05/02/1996 | WO1996012739A1 Immunomodulatory polypeptides |
| 05/02/1996 | WO1996012735A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding |
| 05/02/1996 | WO1996012733A1 Major outer membrane protein cd of moraxella |
| 05/02/1996 | WO1996012544A1 A DIAGNOSTIC ASSAY FOR ALZHEIMER'S DISEASE: ASSESSMENT OF Aβ ABNORMALITIES |
| 05/02/1996 | WO1996012507A1 Antibody reagent for detecting dissecting aortic aneurysm and use thereof |
| 05/02/1996 | WO1996012503A1 Remedy for diseases caused by il-6 production |
| 05/02/1996 | WO1996012501A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2 |
| 05/02/1996 | WO1996012397A2 Recombinant antibody capable of binding to pna/nucleic acid complexes |
| 05/02/1996 | WO1996009386A3 Allelic variation of the serotonin 5ht2c receptor |
| 05/02/1996 | WO1996004011A3 Novel compound to mimic a naturally occurring peptide's effect |
| 05/02/1996 | WO1995027732A3 Circularly permuted ligands and circularly permuted chimeric molecules |
| 05/02/1996 | DE19500394A1 Peptide zur Diagnose, zum Nachweis und zur Prävention von Hepatitis C Virus (HCV)-Infektionen Peptides for diagnosis, for the detection and prevention of hepatitis C virus (HCV) infections |
| 05/02/1996 | CA2652992A1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |